New insulin formula tested for better blood sugar control
NCT ID NCT07282054
Summary
This study tested a new insulin called THDB0206 against a standard insulin combination in Chinese adults with type 1 diabetes. Over 26 weeks, researchers measured how well it controlled blood sugar levels and monitored safety. The goal was to see if the new insulin could be a helpful alternative for daily diabetes management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Drum Tower hospital
Nanjing, China
Conditions
Explore the condition pages connected to this study.